- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 18.02. | Solera Health Launches Behavioral Health Network with Calm and Lyra | ||
| 18.02. | Eli Lilly Joins Chase for Hot Inflammation Target, Paying $100M for Rights to CSL Drug | ||
| 18.02. | Healthcare's AI Obsession Is Missing the Point on Nursing Shortages | ||
| 18.02. | Addressing the 58% Launch Failure Rate: Accelerating Market Access Through Intelligent Decision-Making | ||
| 18.02. | Daffodil Health Secures $16.3M for Health Plan Administration Platform | ||
| 17.02. | Ocular Therapeutix Eyes FDA Filing After Wet AMD Drug Tops Regeneron's Eylea in Phase 3 Test | ||
| 17.02. | Regulatory Innovation as a Catalyst: How New Compliance Strategies Are Speeding Up Healthcare Technology Adoption | ||
| 17.02. | The Future of Pharmacy is Now - Health Systems Must Act to Drive Innovation, Access and Sustainability | ||
| 16.02. | Disc Medicine Rare Disease Drug Picked for Faster Regulatory Review Is Rejected by the FDA | ||
| 16.02. | NYU Langone Health: We're Close to Clinical AI with No Human in the Loop | ||
| 16.02. | From Pilots to Protocols: Why VR Therapy Needs Dosage Standards to Become Real Clinical Care | ||
| 16.02. | When Health Dollars Move to Individuals, Infrastructure Will Decide Who Wins | ||
| 13.02. | PTC Therapeutics Ends Bid to Seek FDA Approval for Rare Muscle Disease Drug | ||
| 13.02. | Closing the CKD Care Gap with Value-Based Care Models | ||
| 13.02. | AI Can't Improve Healthcare if Clinicians and Staff Aren't Trained to Use, Orchestrate It | ||
| 13.02. | COO of Mayo Clinic Platform Believes De-identified Data Leads to Loss of Utility for Pharma, Other Third Parties | ||
| 12.02. | BridgeBio Stands Tall as Phase 3 Data Put Dwarfism Drug on Track for FDA Filing | ||
| 12.02. | Talkiatry Rakes In $210M to Scale Virtual Psychiatry Group | ||
| 12.02. | Empathetic AI Nurses Can Vastly Improve Nurses' Work and Patient Care | ||
| 12.02. | A Guide to the Best Disaster Recovery Solutions for Health Care Organizations | ||
| 12.02. | Blinded by Science: The Importance of RWD and Post-market Surveillance | ||
| 12.02. | The Hidden Administrative Tasks Draining Small Practices | ||
| 11.02. | Why Mount Sinai Chose Microsoft Over Abridge and Suki | ||
| 11.02. | Moderna Says FDA Refusal to Review mRNA Flu Vaccine Contradicts Federal Rules, Prior Guidance | ||
| 11.02. | From Claims Payer to Care Partner: What AI Really Changes in Health Insurance, and What It Doesn't |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.